GE HealthCare Technologies EPS (Diluted) decreased by 33.6% to $0.85 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 30.9%, from $1.23 to $0.85. Over 4 years (FY 2021 to FY 2025), EPS (Diluted) shows relatively stable performance with a -2.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate stronger profitability even when accounting for potential share dilution.
Calculated by dividing net income by the weighted-average number of common shares outstanding, assuming the conversion o...
Used by all public companies to provide a realistic view of earnings per share for investors.
eps_diluted| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.24 | $1.24 | $1.24 | $0.86 | $1.07 | $1.07 | $1.22 | $0.41 | $0.91 | $0.82 | $0.89 | $0.81 | $0.93 | $1.02 | $1.58 | $1.23 | $1.06 | $0.98 | $1.28 | $0.85 |
| QoQ Change | — | +0.0% | +0.0% | -30.5% | +24.4% | +0.0% | +14.0% | -66.4% | +122.0% | -9.9% | +8.5% | -9.0% | +14.8% | +9.7% | +54.9% | -22.2% | -13.8% | -7.5% | +30.6% | -33.6% |
| YoY Change | — | — | — | — | -13.5% | -13.5% | -1.4% | -52.3% | -15.0% | -23.4% | -27.0% | +97.6% | +2.2% | +24.4% | +77.5% | +51.9% | +14.0% | -3.9% | -19.0% | -30.9% |